TriSalus Life Sciences (TLSIW) Invested Capital (2022 - 2025)
Historic Invested Capital for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $6.0 million.
- TriSalus Life Sciences' Invested Capital rose 38545.02% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 38545.02%. This contributed to the annual value of -$3.8 million for FY2024, which is 8592.28% up from last year.
- As of Q3 2025, TriSalus Life Sciences' Invested Capital stood at $6.0 million, which was up 38545.02% from $12.9 million recorded in Q2 2025.
- Over the past 5 years, TriSalus Life Sciences' Invested Capital peaked at $12.9 million during Q2 2025, and registered a low of -$188.3 million during Q2 2023.
- Moreover, its 4-year median value for Invested Capital was -$11.5 million (2022), whereas its average is -$40.6 million.
- As far as peak fluctuations go, TriSalus Life Sciences' Invested Capital plummeted by 153154.12% in 2023, and later skyrocketed by 54886.48% in 2025.
- Quarter analysis of 4 years shows TriSalus Life Sciences' Invested Capital stood at -$160.5 million in 2022, then soared by 83.14% to -$27.1 million in 2023, then skyrocketed by 85.92% to -$3.8 million in 2024, then soared by 258.5% to $6.0 million in 2025.
- Its Invested Capital was $6.0 million in Q3 2025, compared to $12.9 million in Q2 2025 and -$2.7 million in Q1 2025.